Futura Medical PLC (LON:FUM) is stepping up roadshows to highlighting its technology with a presentation to institutional investors today on its topical gel for erectile dysfunction, MED2002.
Part of a capital markets event, the presentation is similar to the one used for potential licensing partners and comprises a detailed insight into key aspects of the clinical development and commercial potential of the product.
Futura believes MED2002 offers the fastest speed of onset, the least side-effects and the fewest contra-indications of any ED medication.
The presentation is available at www.futuramedical.com.
Shares rose 3% to 53p.